Literature DB >> 2550518

Prospective study of community-acquired rotavirus infection.

B J Zheng1, S K Lo, J S Tam, M Lo, C Y Yeung, M H Ng.   

Abstract

We determined titers of group A rotavirus common antibodies and neutralizing antibodies against serotypes 1 to 4 of prototype human rotavirus (HRV) in cord blood and serum specimens obtained from 38 infants at 4-month intervals from birth until 2 years of age. Nineteen of the infants developed one episode of HRV diarrhea each, and they were matched by age and birth weight with the other 19 infants, who did not develop HRV diarrhea during the follow-up period. We estimated the incidence rate of HRV infection for the two groups of infants combined to be a minimum of 1.34 episodes per infant per year, which is 22 times more common than the occurrence of overt disease caused by the virus in this community. The infection occurred constantly throughout the first 2 years of infancy, whereas all but one of the 19 episodes of overt disease occurred before 12 months of age. Seven of these overt episodes were preceded by at least one episode of subclinical infection earlier, and the other seven were probably due to primary HRV infection. The remaining five episodes occurred before 4 months of age, so that we could not ascertain whether they were due to primary infections because of the presence of maternal antibodies. We showed that levels of HRV antibodies in serum specimens obtained before clinical onset of diarrhea varied widely, and, for most infants in the diarrheal group, levels of these antibodies were similar to those in the serum specimens obtained at the same times from the corresponding age- and birth weight-matched control infants. Nevertheless, the age at which overt disease caused by HRV was most prevalent coincided with the time when the maternal antibodies had declined to low levels but the infants had not yet acquired high titers of these antibodies in their sera.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550518      PMCID: PMC267743          DOI: 10.1128/jcm.27.9.2083-2090.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2.

Authors:  A R Kalica; H B Greenberg; R T Espejo; J Flores; R G Wyatt; A Z Kapikian; R M Chanock
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

2.  Rotavirus serotypes by serum neutralisation.

Authors:  G M Beards; J N Pilfold; M E Thouless; T H Flewett
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

3.  Enzyme-linked immunosorbent assays based on polyclonal and monoclonal antibodies for rotavirus detection.

Authors:  G M Beards; A D Campbell; N R Cottrell; J S Peiris; N Rees; R C Sanders; J A Shirley; H C Wood; T H Flewett
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

Review 4.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children.

Authors:  A Z Kapikian; H W Kim; R G Wyatt; W L Cline; J O Arrobio; C D Brandt; W J Rodriguez; D A Sack; R M Chanock; R H Parrott
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

6.  Direct identification of serotypes of natural human rotavirus isolates by hybridization using cDNA probes derived from segment 9 of the rotavirus genome.

Authors:  B J Zheng; W P Lam; Y K Yan; S K Lo; M L Lung; M H Ng
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

7.  Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve.

Authors:  R F Bishop; E Cipriani; J S Lund; G L Barnes; C S Hosking
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

8.  Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.

Authors:  T Vesikari; E Isolauri; E D'Hondt; A Delem; F E André; G Zissis
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

9.  Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels.

Authors:  A J Herring; N F Inglis; C K Ojeh; D R Snodgrass; J D Menzies
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

10.  Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Authors:  R F Bishop; G L Barnes; E Cipriani; J S Lund
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

View more
  7 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Distinct populations of rotaviruses circulating among neonates and older infants.

Authors:  J S Tam; B J Zheng; S K Lo; C Y Yeung; M Lo; M H Ng
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays.

Authors:  D O Matson; M L O'Ryan; L K Pickering; S Chiba; S Nakata; P Raj; M K Estes
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran.

Authors:  S Sharifipour; K Davoodi Rad
Journal:  New Microbes New Infect       Date:  2020-01-07

Review 6.  Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis.

Authors:  Joke Bilcke; Pierre Van Damme; Marc Van Ranst; Niel Hens; Marc Aerts; Philippe Beutels
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240

Review 7.  Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.

Authors:  Juana Angel; A Duncan Steele; Manuel A Franco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.